Source:http://linkedlifedata.com/resource/pubmed/id/17475881
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2007-5-3
|
pubmed:abstractText |
Epidermolysis bullosa acquisita is a subepidermal blistering disease associated with tissue-bound and circulating autoantibodies against type VII collagen, a major constituent of the dermal-epidermal junction. The passive transfer of Abs against type VII collagen into mice induces a subepidermal blistering disease dependent upon activation of terminal complement components. To further dissect the role of the different complement activation pathways in this model, we injected C1q-deficient, mannan-binding lectin-deficient, and factor B-deficient mice with rabbit Abs against murine type VII collagen. The development and evolution of blistering had a similar pattern in mannan-binding lectin-deficient and control mice and was initially only marginally less extensive in C1q-deficient mice compared with controls. Importantly, factor B-deficient mice developed a delayed and significantly less severe blistering disease compared with factor B-sufficient mice. A significantly lower neutrophilic infiltration was observed in factor B-deficient mice compared with controls and local reconstitution with granulocytes restored the blistering disease in factor B-deficient mice. Our study provides the first direct evidence for the involvement of the alternative pathway in an autoantibody-induced blistering disease and should facilitate the development of new therapeutic strategies for epidermolysis bullosa acquisita and related autoimmune diseases.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type VII,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C1q,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Mannose-Binding Lectin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
178
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6514-21
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17475881-Animals,
pubmed-meshheading:17475881-Autoantibodies,
pubmed-meshheading:17475881-Blister,
pubmed-meshheading:17475881-Collagen Type VII,
pubmed-meshheading:17475881-Complement C1q,
pubmed-meshheading:17475881-Complement Pathway, Alternative,
pubmed-meshheading:17475881-Epidermolysis Bullosa Acquisita,
pubmed-meshheading:17475881-Genetic Predisposition to Disease,
pubmed-meshheading:17475881-Immunoglobulin G,
pubmed-meshheading:17475881-Mannose-Binding Lectin,
pubmed-meshheading:17475881-Mice,
pubmed-meshheading:17475881-Mice, Inbred BALB C,
pubmed-meshheading:17475881-Mice, Inbred C57BL,
pubmed-meshheading:17475881-Mice, Knockout
|
pubmed:year |
2007
|
pubmed:articleTitle |
The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.
|
pubmed:affiliation |
Department of Dermatology, University of Lübeck, Lübeck, Germany, and Department of Pediatrics, Laboratory of Developmental Immunology, Massachusetts General Hospital, Boston 02115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|